These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
410 related items for PubMed ID: 26088886
1. Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials. Ma J, Huang S, You C. Epilepsy Res; 2015 Aug; 114():59-65. PubMed ID: 26088886 [Abstract] [Full Text] [Related]
2. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial. Biton V, Berkovic SF, Abou-Khalil B, Sperling MR, Johnson ME, Lu S. Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953 [Abstract] [Full Text] [Related]
3. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial. Ryvlin P, Werhahn KJ, Blaszczyk B, Johnson ME, Lu S. Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083 [Abstract] [Full Text] [Related]
4. The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies. Tian X, Yuan M, Zhou Q, Wang X. Expert Opin Pharmacother; 2015 Jan; 16(12):1755-67. PubMed ID: 26165169 [Abstract] [Full Text] [Related]
5. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures. Klein P, Schiemann J, Sperling MR, Whitesides J, Liang W, Stalvey T, Brandt C, Kwan P. Epilepsia; 2015 Dec; 56(12):1890-8. PubMed ID: 26471380 [Abstract] [Full Text] [Related]
6. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial. Kwan P, Trinka E, Van Paesschen W, Rektor I, Johnson ME, Lu S. Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853 [Abstract] [Full Text] [Related]
7. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial. Van Paesschen W, Hirsch E, Johnson M, Falter U, von Rosenstiel P. Epilepsia; 2013 Jan; 54(1):89-97. PubMed ID: 22813235 [Abstract] [Full Text] [Related]
8. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs. Brigo F, Bragazzi NL, Nardone R, Trinka E. Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868 [Abstract] [Full Text] [Related]
9. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies. Moseley BD, Sperling MR, Asadi-Pooya AA, Diaz A, Elmouft S, Schiemann J, Whitesides J. Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437 [Abstract] [Full Text] [Related]
10. Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trial. Inoue Y, Tiamkao S, Zhou D, Cabral-Lim L, Lim KS, Lim SH, Tsai JJ, Moseley B, Wang L, Sun W, Hayakawa Y, Sasamoto H, Sano T, McClung C, Bass A. Epilepsia Open; 2024 Jun; 9(3):1007-1020. PubMed ID: 38576178 [Abstract] [Full Text] [Related]
11. Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial. Klein P, McLachlan R, Foris K, Nondonfaz X, Elmoufti S, Dimova S, Brandt C. Epilepsy Res; 2020 Nov; 167():106369. PubMed ID: 32717713 [Abstract] [Full Text] [Related]
13. Brivaracetam add-on for refractory focal epilepsy: A systematic review and meta-analysis. Lattanzi S, Cagnetti C, Foschi N, Provinciali L, Silvestrini M. Neurology; 2016 Apr 05; 86(14):1344-1352. PubMed ID: 26944275 [Abstract] [Full Text] [Related]
14. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies. Ben-Menachem E, Mameniškienė R, Quarato PP, Klein P, Gamage J, Schiemann J, Johnson ME, Whitesides J, McDonough B, Eckhardt K. Neurology; 2016 Jul 19; 87(3):314-23. PubMed ID: 27335114 [Abstract] [Full Text] [Related]
15. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures. Mumoli L, Palleria C, Gasparini S, Citraro R, Labate A, Ferlazzo E, Gambardella A, De Sarro G, Russo E. Drug Des Devel Ther; 2015 Jul 19; 9():5719-25. PubMed ID: 26543353 [Abstract] [Full Text] [Related]
16. Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures. Toledo M, Whitesides J, Schiemann J, Johnson ME, Eckhardt K, McDonough B, Borghs S, Kwan P. Epilepsia; 2016 Jul 19; 57(7):1139-51. PubMed ID: 27265725 [Abstract] [Full Text] [Related]
17. Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis. Benbadis S, Klein P, Schiemann J, Diaz A, Elmoufti S, Whitesides J. Epilepsy Behav; 2018 Mar 19; 80():129-134. PubMed ID: 29414542 [Abstract] [Full Text] [Related]
18. Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany. Steinig I, von Podewils F, Möddel G, Bauer S, Klein KM, Paule E, Reif PS, Willems LM, Zöllner JP, Kunz R, Runge U, Kurlemann G, Schubert-Bast S, Rosenow F, Strzelczyk A. Epilepsia; 2017 Jul 19; 58(7):1208-1216. PubMed ID: 28480518 [Abstract] [Full Text] [Related]
19. Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial. French JA, Costantini C, Brodsky A, von Rosenstiel P, N01193 Study Group. Neurology; 2010 Aug 10; 75(6):519-25. PubMed ID: 20592253 [Abstract] [Full Text] [Related]
20. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST). Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C, BRIVAFIRST Group Membership. CNS Drugs; 2021 Dec 10; 35(12):1289-1301. PubMed ID: 34476770 [Abstract] [Full Text] [Related] Page: [Next] [New Search]